Ad is loading...
MENU
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AC Immune SA (ACIU) Ownership - Who owns AC Immune SA?

Profile

Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
315.63M
P/E Ratio
N/A
Total Cash
175.12M
Projected Growth
N/A
Total Debt
3.23M
Revenue
15.49M
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash/Share
1.77
Total Debt/Equity
N/A
Revenue/Share
0.48 USD as % of share price

Fundamentals

ACIU
Capitalization
316M
P/E Ratio
N/A
Risk (Beta)
1.28
Dividend Yield
N/A
Total Cash
175M
Total Cash/Share
1.77
Total Debt
3.23M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.48%
Revenue
15.5M
ROE
N/A
Book Value
123M
P/B Ratio
2.16
Cash Flow
N/A
Earnings
-0.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.21M
Current Ratio
1.80
Current Revenue Per Employee
4267.08
Dividends Per Share - Security
N/A
EBITDA
-58.18M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-30.73
Shares Held By Institutions
124M
Shares Outstanding - Current
98.9M
Total Liabilities
114M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-36.200
View a ticker or compare two or three
ACIU
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com